News 19.11.20

Pharming announces commitment to building a new downstream manufacturing facility at Pivot Park

Pharming announces commitment to building a new downstream manufacturing facility at Pivot Park

Read more
News 17.11.20

Lead Pharma enters into a Research Collaboration with Roche

Lead Pharma enters into a Research Collaboration and License Agreement with Roche.

Read more
News 11.11.20

PharmaCytics and Madam Therapeutics announce collaboration to develop a new class of oral anti-biotics

PharmaCytics and Madam Therapeutics announce collaboration to develop a new class of oral anti-biotics.

Read more
News 19.10.20

Press release Glycostem

12th October 2020 - Glycostem announces it has received the FDA’s Orphan Drug Designation (ODD) for treatment of Multiple Myeloma (MM) patients with its investigational product oNKord®.

Read more
News 09.10.20

CEO round table ‘What about business in 2021′ – Webinar

WEBINAR LifetecZONe round table ‘What about business in 2021′ vanuit Pivot Park 3 november @ 12:00 – 13:00   4...

Read more
News 01.09.20

Pivot Park gaat aan de wandel

Na een kalme periode op het life sciences park vanwege thuiswerken door corona en de zomer vakanties, worden de medewerkers bij terugkomst op de campus in Oss aan de wandel gezet om een gezonde lifestyle te stimuleren en te behouden.

Read more
News 05.08.20

BG.legal receives grant for AI knowledge platform

BG.legal has received a grant from the Promotion Fund (‘Stimuleringsfonds’) of the Metropolitan Region Eindhoven for the 'Legal AIR' project. With the grant, BG.legal will create a knowledge platform with information on legal aspects of Artificial Intelligence.

Read more
News 22.07.20

Industry veterans Paul Peter Tak and Eric Meldrum join Citryll’s Board

Citryll announced its Board has been strengthened with two industry veterans with impressive track-records. “We warmly welcome Paul Peter and Eric and are incredibly honoured to have them on the Board of Citryll. Their impressive and complementary track records in drug discovery and development in pharma, biotech and academia will add significant value to the progression of our NET inhibiting development candidate CIT-013”

Read more
News 14.07.20

Pivot Park heeft een uitdaging voor jou!

Heb jij een HBO-diploma in een technische richting, ervaring in de installatiebranche en affiniteit met de Life Sciences omgeving? Dan...

Read more